Enzymes in Drug Discovery Summit
Venue: Hard Rock Hotel San Diego, San Diego, CA, USA
Date: 8 - 9 February, 2017
GTCbio conferences aim to facilitate transformational platforms that would have a significant impact on scientific research, drug development and healthcare. Identifying and validating new targets is a critical starting point and often times a daunting inflection point in drug development. While there is continuous innovation and invention of new assays and screening technologies, it is important to understand how these technologies will help with new and existing targets. Protein Kinases have long been an important target in several diseases and we will discuss new developments in this area at our 2017 Enzymes in Drug Discovery Summit. We will also focus on advances in Ubiquitin and Protease targeted therapies.
Please join us to be part of an exciting platform at the Enzymes in Drug Discovery Summit, which will take place February 8-9, 2017 in San Diego, CA.
This summit will feature the following three conferences:
3rd Protease Inhibitors in Drug Discovery
In addition to scientific presentations, dedicated networking sessions will allow you to connect and form new relationships with colleagues from both the private and public sector.
We hope to see you there!
The 2017 Advisory Committee